Skip to main content

UBS Group AG

Position in ATOS — Atossa Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ATOS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$159,456
-$324,642 QoQ
Shares Held
82,620
-10.2% QoQ
Ownership
0.828%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 31 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. ATOS ranks #346 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATOS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $159,456 82,620
2026-03-31 $484,098 92,034
2025-12-31 $230,104 390,008
2025-09-30 $226,828 260,722
2025-06-30 $342,343 412,462
2025-03-31 $305,108 455,386
2024-12-31 $1,057,220 1,124,703
2024-09-30 $107,604 70,793
2024-06-30 $49,326 41,451
2024-03-31 $761 423
2023-12-31 $26 30
2023-09-30 $24,685 33,359
2022-09-30 $297 359
2022-06-30 $6,314 5,793
2022-03-31 $45,110 36,089
2021-12-31 $116,513 72,821
2021-09-30 $132,567 40,665
2021-03-31 $55,218 26,170
2020-09-30 $9,329 3,855
2020-06-30 $6,034 1,588